Condition
Corona Virus Disease 19 (COVID-19)
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07068282Phase 1CompletedPrimary
The Effect of Novel D3 Use as a Mouthwash in COVID-19 Patients
NCT04381338Not ApplicableCompletedPrimary
Rehabilitation for People With COVID-19 in ICU
NCT04792021Phase 3CompletedPrimary
Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients
Showing all 3 trials